ARO-C3 treatment led to deep and sustained reductions in alternative pathway complement activity and proteinuria. ARO-C3, an investigational RNA interference-based therapy targeting hepatic expression ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback